Clinical trials: Diarrhea Bloody
Multiple Myeloma, Diarrhea
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
The purpose of this study is to test the safety of colesevelam and find out what effects, if any, colesevelam has on lenalidomide associated diarrhea in participants with multiple myeloma on lenalidomide maintenance.
- Trial name
- NCT03767257
- Testing
- Colesevelam Pill
- Where
- 7 sites in United States
- Volunteers
- 25 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Diarrhea Bloody
Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia
Children presenting for emergency department (ED) care with bloody diarrhea (i.e. hematochezia) represent a diagnostic challenge.
- Trial name
- NCT03362970
- Testing
- BioFire Gastrointestinal Panel FilmArray®, Standard of Care
- Where
- Canada
- Volunteers
- 60 people
- Sponsor
- University of Calgary
Multiple Myeloma
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
For patients who receive a hematopoietic cell transplant (HCT), there is a risk of developing a diarrhea secondary to the chemotherapy which we give.
- Trial name
- NCT02619812
- Testing
- Serum-derived bovine immunoglobulin/protein isolate (SBI), Colesevelam
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Mayo Clinic